About Srvatra Pharma
Srvatra Pharma is a Healthcare company based in Solan (India) founded in 2022. Pharmaceutical trading company supplying tablets, capsules, and injections to clients. It operates on a B2B model. Its Indian entity Srvatra Pharma India Private Limited reported revenue of ₹1.2 Lakh. Srvatra Pharma offers products and services including SRVAZITH-500, SRVATAMOL-650, SRVAFLOX-OZ, SRVAFLUC-150, and SRVAFENAC P. Its focus areas include Pharmaceuticals, Trading, Drug Distribution and Medicinal Products. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Srvatra Pharma is a pharmaceutical trading company founded in 2022, specializing in selling and supplying high-quality medicines like tablets, capsules, and injections. Based in India, it procures, tests, and distributes products through efficient logistics to meet clients needs in various therapeutic areas, ensuring safety and regulatory compliance.
- Headquarters Solan, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website srvatrapharma.com
- Social LinkedIn X Facebook Instagram
- Legal Name Srvatra Pharma India Private Limited
- Date of Incorporation 11 Nov, 2020
- Jurisdiction Baddi, Himachal Pradesh, India
- Annual Revenue₹1.2 Lakh
FY 2025 · +49% YoY
- Net Loss-₹2.8 Lakh
FY 2025 · -224% margin
- EBITDA-₹2.5 Lakh
FY 2025 · -204% margin
Associated legal entities of Srvatra Pharma
Srvatra Pharma operates through Srvatra Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Srvatra Pharma India Private Limited CIN U52311HP2020PTC008211 | Active | 11 Nov 2020 | Baddi, Himachal Pradesh | ₹0.0 Cr | 3 | View details |
Products & Services of Srvatra Pharma
Srvatra Pharma offers a comprehensive portfolio of products and services, including SRVAZITH-500, SRVATAMOL-650, SRVAFLOX-OZ, SRVAFLUC-150, and SRVAFENAC P.
Antibiotic tablet for treating bacterial infections.
Pain relief tablet containing paracetamol.
Antibiotic tablet for infections and parasitic issues.
Antifungal tablet for fungal infections.
Anti-inflammatory tablet for pain and fever.
Capsule for erectile dysfunction treatment.
Antibiotic capsule for bacterial infections.
Gastric capsule for acid-related issues.
Antibiotic syrup for children’s infections.
Board of directors of Srvatra Pharma India Private Limited (Srvatra Pharma)
Srvatra Pharma India Private Limited is the primary company behind Srvatra Pharma. The board of Srvatra Pharma India Private Limited currently have 3 directors; the longest-serving is Anshul Verma, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anshul Verma DIN 07325207 | Director | 11 Nov 2020 | 5 yrs 11 mo | Srvatra Pharma India Private Limited |
| Vishal Sud DIN 08560129 | Director | 11 Nov 2020 | 5 yrs 11 mo | Srvatra Pharma India Private Limited |
| Varun Sud DIN 03016935 | Additional Director | 07 Jan 2022 | 4 yrs 9 mo | Srvatra Pharma India Private Limited |
Financials of Srvatra Pharma
Figures of Srvatra Pharma India Private Limited, the primary company behind Srvatra Pharma, for FY 2025. Revenue was ₹1.2 Lakh (+49% year on year). Net loss was -₹2.8 Lakh (-224% margin). EBITDA was -₹2.5 Lakh (-204% margin). Revenue has grown at a compounded annual rate of +84% over three years.
- ₹1.2 LakhRevenue · FY 2025 · +49% YoY
- -₹2.8 LakhNet loss · -224% margin
- -₹2.5 LakhEBITDA · -204% margin
- ₹1 LakhPaid-up capital
- +84%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Srvatra Pharma India Private Limited are on its company page.
Detailed financial statements for Srvatra Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Srvatra Pharma
Srvatra Pharma has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Srvatra Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Srvatra Pharma
Srvatra Pharma was founded in 2022.
Srvatra Pharma is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.
The primary company behind Srvatra Pharma, Srvatra Pharma India Private Limited, reported revenue of ₹1.2 Lakh for FY 2025, up 49% year on year.
Srvatra Pharma is a pharmaceutical trading company founded in 2022, specializing in selling and supplying high-quality medicines like tablets, capsules, and injections. Based in India, it procures, tests, and distributes products through efficient logistics to meet clients needs in various therapeutic areas, ensuring safety and regulatory compliance.
Srvatra Pharma's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Srvatra Pharma offers SRVAZITH-500, SRVATAMOL-650, SRVAFLOX-OZ, SRVAFLUC-150, and 5 more products and services.
Srvatra Pharma operates through Srvatra Pharma India Private Limited.
The legal entities of Srvatra Pharma currently have 3 directors, including Anshul Verma, Vishal Sud, Varun Sud.